Tsukuba, Japan

Akio Kanatani

This inventor holds 46 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents, primarily in Chemical Compounds. Top assignees: Banyu Pharmaceutical Co. Ltd, Msd K.k., Merck + Co., Inc.. Active years: 2000-2012.

USPTO Granted Patents = 46 

% Patents Active = 45.7

 

Average Co-Inventor Count = 5.7

ph-index = 9

Forward Citations = 303(Granted Patents)


Location History:

  • Ibaraki, JP (2001 - 2003)
  • Tsukkuba, JP (2009)
  • Ushiku, JP (2009 - 2011)
  • Tsukuba, JP (2000 - 2012)

Company Filing History:


Years Active: 2000-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Piperidine Derivatives
Benzimidazole Derivatives
Receptor Antagonists
Quinazoline Derivative
Azole Derivatives
Imidazopyridine Compounds
Spiro Compounds
Nitrogenous Heterocycles
Fused Ring Compounds
Melanin-Concentrating Hormone
Neuropeptide Y
Heteroaryloxy Compounds
46 patents (USPTO):Explore Patents

Title: The Innovative Journey of Akio Kanatani

Introduction:

Akio Kanatani is a visionary inventor hailing from Tsukuba, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Akio Kanatani holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his commitment to pushing the boundaries of what is possible in the modern world.

Career Highlights:

With a career spanning over two decades, Akio Kanatani has worked with some of the leading research institutions and tech companies in Japan, honing his skills and expertise in developing cutting-edge solutions to complex problems.

Collaborations:

Throughout his career, Akio Kanatani has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to the successful development of revolutionary products and technologies.

Conclusion:

In conclusion, Akio Kanatani stands as a beacon of inspiration in the world of invention, continuously striving to create a better future through his pioneering work and unwavering dedication to innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…